“…(Dow et al, 2002;Werbovetz et al, 2003)), while GB-II-5 is approximately 5-fold more active against L. donovani axenic amastigotes and about 60-fold more active against T. brucei bloodstream forms than against intraerythrocytic P. falciparum (K. Werbovetz, unpublished data). Experimental evidence indicates that the binding site for oryzalin is on α-tubulin (Anthony and Hussey, 1999;Morrissette et al, 2004). In the apicomplexan parasite Toxoplasma gondii, molecular simulations suggest that the oryzalin binding site consists of α-tubulin residues Arg2, Glu3, Val4, Trp21, Phe24, His28, Ile42, Asp47, Arg64, Cys65, Thr239, Arg243, and Phe244 (Morrissette et al, 2004).…”